A Randomized, Multicenter, Placebo-Controlled Trial of the Beta3 Adrenergic Agonist, Mirabegron on Left Ventricular Mass and Diastolic Function in Patients With Structural Heart Disease, the Beta3lvh Trial

被引：0
|
作者：
Balligand, Jean-Luc [1 ]
机构：
[1] UCLouvain, Pharmacol & Therapeut, Brussels, Belgium
来源：
CIRCULATION | 2022年 / 146卷 / 25期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
19692
引用
收藏
页码：E591 / E591
页数：1
相关论文
共 50 条
  • [1] Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH)
    Pouleur, Anne-Catherine
    Anker, Stefan
    Brito, Dulce
    Brosteanu, Oana
    Hasenclever, Dirk
    Casadei, Barbara
    Edelmann, Frank
    Filippatos, Gerasimos
    Gruson, Damien
    Ikonomidis, Ignatios
    Lhommel, Renaud
    Mahmod, Masliza
    Neubauer, Stefan
    Persu, Alexandre
    Gerber, Bernhard L.
    Piechnik, Stefan
    Pieske, Burkert
    Pieske-Kraigher, Elisabeth
    Pinto, Fausto
    Ponikowski, Piotr
    Senni, Michele
    Trochu, Jean-Noel
    Van Overstraeten, Nancy
    Wachter, Rolf
    Balligand, Jean-Luc
    ESC HEART FAILURE, 2018, 5 (05): : 831 - 842
  • [2] Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH) (vol 5, pg 830, 2018)
    Pinto, Fausto
    ESC HEART FAILURE, 2018, 5 (06): : 1199 - 1199
  • [3] Repurposing the β3-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease The Beta3-LVH Phase 2b Randomized Clinical Trial
    Balligand, Jean-Luc
    Brito, Dulce
    Brosteanu, Oana
    Casadei, Barbara
    Depoix, Christophe
    Edelmann, Frank
    Ferreira, Vanessa
    Filippatos, Gerasimos
    Gerber, Bernhard
    Gruson, Damien
    Hasenclever, Dirk
    Hellenkamp, Kristian
    Ikonomidis, Ignatios
    Krakowiak, Bartosz
    Lhommel, Renaud
    Mahmod, Masliza
    Neubauer, Stefan
    Persu, Alexandre
    Piechnik, Stefan
    Pieske, Burkert
    Pieske-Kraigher, Elisabeth
    Pinto, Fausto
    Ponikowski, Piotr
    Senni, Michele
    Trochu, Jean-Noel
    Van Overstraeten, Nancy
    Wachter, Rolf
    Pouleur, Anne-Catherine
    JAMA CARDIOLOGY, 2023, 8 (11) : 1031 - 1040
  • [4] Protocol for a multicenter randomized, double blind, controlled pilot trial of higher neural function in overactive bladder patients after anticholinergic, beta-3 adrenergic agonist, or placebo
    High, Rachel A.
    Danford, Jill M.
    Shi, Zhaoyue
    Karmonik, Christof
    Kuehl, Thomas J.
    Bird, Erin T.
    Khavari, Rose
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2020, 19
  • [5] The first-in-man randomized trial of a beta3 adrenoceptor agonist in chronic heart failure: the BEAT-HF trial
    Bundgaard, Henning
    Axelsson, Anna
    Thomsen, Jakob Hartvig
    Sorgaard, Mathias
    Kofoed, Klaus F.
    Hasselbalch, Rasmus
    Fry, Natasha A. S.
    Valeur, Nana
    Boesgaard, Soren
    Gustafsson, Finn
    Kober, Lars
    Iversen, Kasper
    Rasmussen, Helge H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (04) : 566 - 575
  • [6] Randomized, Placebo-Controlled Trial of an Aerosolized Beta-2 Adrenergic Agonist (Albuterol) for the Treatment of Acute Lung Injury
    Matthay, M. A.
    Brower, R.
    Thompson, B. T.
    Schoenfeld, D.
    Eisner, M. D.
    Carson, S.
    Moss, M.
    Douglas, I.
    Hite, D.
    MacIntyre, N.
    Liu, K. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [7] IMPROVEMENT OF LEFT-VENTRICULAR CONTRACTILITY AND RELAXATION WITH THE BETA-1-ADRENERGIC RECEPTOR PARTIAL AGONIST XAMOTEROL AT REST AND DURING EXERCISE IN PATIENTS WITH POSTINFARCTION LEFT-VENTRICULAR DYSFUNCTION - A PLACEBO-CONTROLLED RANDOMIZED TRIAL
    DEFEYTER, PJ
    SERRUYS, PW
    SURYAPRANATA, H
    CIRCULATION, 1990, 81 (02) : 99 - 106
  • [8] Protocol for a multicenter randomized, double blind, controlled pilot trial of higher neural function in overactive bladder patients after anticholinergic, beta-3 adrenergic agonist, or placebo (vol 19, 100621, 2020)
    High, R. A.
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2020, 20
  • [9] A Randomized Placebo-Controlled Trial of Omega-3 and Sertraline in Depressed Patients With or at Risk for Coronary Heart Disease
    Carney, Robert M.
    Freedland, Kenneth E.
    Rubin, Eugene H.
    Rich, Michael W.
    Steinmeyer, Brian C.
    Harris, William S.
    JOURNAL OF CLINICAL PSYCHIATRY, 2019, 80 (04)
  • [10] A Multicenter, Double-blind, Randomized, Placebo-controlled Trial of the β3-Adrenoceptor Agonist Solabegron for Overactive Bladder
    Ohlstein, Eliot H.
    von Keitz, Alexander
    Michel, Martin C.
    EUROPEAN UROLOGY, 2012, 62 (05) : 834 - 840
12345